作者: L. Dufrechou , A. Larre Borges , M. Nin , L. Curi , F. González
DOI: 10.1016/J.TRANSPROCEED.2011.09.088
关键词:
摘要: Uruguay is the second country of Latin America in prevalence renal replacement therapies, including functioning kidney allografts. Long-term immunosuppressive therapy essential for adequate graft function, but results reduced immunosurveillance leading to an increased risk complications such as infections and malignancies. A variety cutaneous manifestations well increase non-melanoma skin cancers have been reported this population. The objective study was evaluate frequency clinical spectrum reno-pancreatic recipients Uruguay. One hundred or aged between 21- 77-years-old were evaluated September 2009 2010. total 104 dermatoses observed; 68% patients had at least one manifestation. most frequent side effects due treatment (43.3%), followed by (27.9%), miscellaneous causes (22.1%), malignant premalignant lesions (6.7%). This first evaluating dermatological organ transplant our country. Most manifestation immunosuppression, a pre-malignant lesion, highlighting that high-risk Cancer important death with grafts. Its prevention major goal care recipients. Physicians units should be aware importance screening cancer surveillance.